Published

Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Fundamental & clinical pharmacology
Date: 2025-08-01
Source: PubMed
DOI: 10.1111/fcp.70038
PubMed: 40670864

Authors

Adebo M Bonnet M Laouej O Defaix C McGowan JC Butlen-Ducuing F David DJ Poupon E Tritschler L Gardier AM

Watch author

Derived topics and classifications

psilocybin psilocin Depression Anxiety Addiction Neuroplasticity Pharmacology Mechanism of Action Receptor Pharmacology Clinical Trial Review Article Animal Study Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 3 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions2026-07-02 Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress2026-01-02 Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.2025-08-01

Related papers

Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimizationFrontiers in Psychiatry · 2025-04-08 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024-12-02 A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceClinicalTrials.gov · 2022-11-08 Crystal structures of the Teonanácatl hallucinogens. Part II. Psilocin, C12 H15 N2 OJ. Chem. Soc., Perkin Trans. 2 · 1974-01-01 Occurrence of psilocybin in the sporophores of Psilocybe semilanceataTransactions of the British Mycological Society · 1969-10-01